Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
ASBPCompany Name
ASPIRE BIOPHARMA HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQASPIRE BIOPHARMA HOLDINGS INC - Cash Return on Invested Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ASBP - CROIC Historical data
| Date | Cash Return on Invested Capital | Free Cash Flow | Invested Capital |
|---|---|---|---|
| 6/30/2025 | 0% | $ -304.72K | $ -1.14M |
| 3/31/2025 | 0% | $ 243.28K | $ -188.56K |
| 12/31/2024 | 0% | $ -265.19K | $ -273.26K |
| 9/30/2024 | 0% | $ -2.98M | $ -1.17M |
| 6/30/2024 | 0% | $ -3.13M | $ -540.76K |
| 3/31/2024 | 0% | $ -2.73M | $ -568.37K |
| 12/31/2023 | 0% | $ -653.11K | $ -309.72K |
| 9/30/2023 | 0% | $ -532.85K | $ -62.95K |
| 6/30/2023 | -173.63% | $ -454.55K | $ 261.79K |
| 3/31/2023 | 0% | $ -302.97K | $ -10.26M |
Key Performance Insights, Last 5 Years
- ASPIRE BIOPHARMA HOLDINGS INC's latest trailing twelve months (TTM) CROIC stands at -100.2%.
- Over the past 5 years, ASPIRE BIOPHARMA HOLDINGS INC's average CROIC has been -136.92%.
- The median CROIC for ASPIRE BIOPHARMA HOLDINGS INC during this period was -136.92%
- ASPIRE BIOPHARMA HOLDINGS INC reached its highest CROIC over the past 5 years at -100.2%.
- The lowest CROIC recorded by ASPIRE BIOPHARMA HOLDINGS INC in the same timeframe -173.63%
Similar metrics to Inv. Capital:
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
- Invested Capital - [Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditures Margin - [Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
Definition of Cash Return on Invested Capital
[Calculation] Cash Return on Invested Capital (CROIC) measures how well a company uses its invested capital to produce cash. It is calculated as Free Cash Flow [FCF] divided by invested capital [InvCapital].FCF / Inv. Capital
(=) CROIC CROIC for ASPIRE BIOPHARMA HOLDINGS INC is calculated as follows: FCF [ $ -238.6K ] / Inv. Capital [ $ 238.12K ]
(=) CROIC [ -100.2% ] ASBP - Cash Return on Invested Capital, Last 5 years
-173.63%
Minimum
Jun 30, 2023
-100.2%
Maximum
Dec 31, 2021
-136.92%
Average
-136.92%
Median
CROIC Benchmark AnalysisMarket
The chart above depicts the distribution of CROIC for companies in the Total Stock Market. The average CROIC of the companies is 2.84% with a standard deviation of 15.02%.
The following table provides additional summary stats:
CROIC in the Market:
| filtered constituents | 3.46K |
|---|---|
| min | -43.78% |
| max | 49.57% |
| average | 2.84% |
| median | 5.02% |
| std | 15.02% |